Oncovista Innovative Therapies Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
4
- Investments
-
3
Oncovista Innovative Therapies General Information
Description
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.
Contact Information
Website
www.oncovista.comCorporate Office
- 14785 Omicron Drive
- Suite 104
- San Antonio, TX 78245
- United States
Corporate Office
- 14785 Omicron Drive
- Suite 104
- San Antonio, TX 78245
- United States
Oncovista Innovative Therapies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oncovista Innovative Therapies Comparisons
Industry
Financing
Details
Oncovista Innovative Therapies Competitors (84)
One of Oncovista Innovative Therapies’s 84 competitors is Mustang Bio, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mustang Bio | Formerly VC-backed | Waltham, MA | ||||
| Agios Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| VBI Vaccines | Corporation | Cambridge, MA | ||||
| CTI BioPharma | Formerly VC-backed | Seattle, WA |
Oncovista Innovative Therapies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oncovista Innovative Therapies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oncovista Innovative Therapies Investments & Acquisitions (3)
Oncovista Innovative Therapies’s most recent deal was a Corporate with AdnaGen for . The deal was made on 18-Jun-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AdnaGen | 18-Jun-2008 | Corporate | Diagnostic Equipment | ||
| AdnaGen | 17-Dec-2007 | Corporate | Diagnostic Equipment | ||
| AdnaGen | 23-Feb-2006 | Merger/Acquisition | Diagnostic Equipment |
Oncovista Innovative Therapies Exits (3)
Oncovista Innovative Therapies’s most recent exit was on 18-Jun-2008 from AdnaGen. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AdnaGen | 18-Jun-2008 | Completed |
|
||
| AdnaGen | 17-Dec-2007 | Completed |
|
||
| AdnaGen | 23-Feb-2006 | Merger/Acquisition | Completed |
Oncovista Innovative Therapies FAQs
-
When was Oncovista Innovative Therapies founded?
Oncovista Innovative Therapies was founded in 2004.
-
Where is Oncovista Innovative Therapies headquartered?
Oncovista Innovative Therapies is headquartered in San Antonio, TX.
-
What is the size of Oncovista Innovative Therapies?
Oncovista Innovative Therapies has 4 total employees.
-
What industry is Oncovista Innovative Therapies in?
Oncovista Innovative Therapies’s primary industry is Drug Discovery.
-
Is Oncovista Innovative Therapies a private or public company?
Oncovista Innovative Therapies is a Private company.
-
What is Oncovista Innovative Therapies’s current revenue?
The current revenue for Oncovista Innovative Therapies is .
-
How much funding has Oncovista Innovative Therapies raised over time?
Oncovista Innovative Therapies has raised $6.8M.
-
Who are Oncovista Innovative Therapies’s competitors?
Mustang Bio, Agios Pharmaceuticals, CytomX Therapeutics, VBI Vaccines, and CTI BioPharma are some of the 84 competitors of Oncovista Innovative Therapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
